Ekso Bionics Holdings, Inc.
EKSO · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $0 | $1 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $1 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -1.9% | 41.6% | 14.8% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 53.1% | 49.7% | 48.1% | 60% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -52.7% | -72.2% | -108.7% | -80.8% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -63.2% | -83.1% | -116.8% | -86.8% |
| EPS Diluted | -0.56 | -1.1 | -1.16 | -0.88 |
| % Growth | 49.1% | 5.2% | -31.8% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |